Today, the main choice for diagnosing Celiac Disease is to perform a blood test to assess the presence of specific antibodies, marking the presence of the disease. If positive, the physician will generally perform an endoscopy and sample a biopsy in the small bowel, in order to confirm the disease.
While the rate of diagnosis is increasing, the clinical prevalence does not approach the actual prevalence of the disease based on antibody screening, indicating that Celiac Disease is grossly under-diagnosed. The average delay in diagnosis for adult patients with Celiac Disease ranges from 4 to 11 years in North America.
Under-diagnosis is mainly attributed to the under-use of laboratory serological tests by physicians.
Simtomax® is replicating the laboratory serological tests, providing accurate results in just 10 minutes instead of days. It is however not intended to replace the need for a small bowel biopsy, which remain absolutely required if Simtomax® shows positive.